Corbus Pharmaceuticals synthesizes new cannabinoid CB1 receptor antagonists or inverse agonists
Corbus Pharmaceuticals synthesizes new cannabinoid CB1 receptor antagonists or inverse agonists
Body unavailable. Use the original source.
Corbus Pharmaceuticals synthesizes new cannabinoid CB1 receptor antagonists or inverse agonists
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.